Jeri W Nieves
Hospital for Special Surgery, New York
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jeri W Nieves as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:28 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT04467983 · Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab AloneHospital for Special Surgery, New York · active not recruiting · Osteoporosis, Postmenopausal · study director
- Ph2NCT04249232 · Abaloparatide and Pelvic Fracture HealingHospital for Special Surgery, New York · completed · Fracture of Pelvis (Disorder) · principal investigator
- Ph2NCT02972424 · PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled TrialHospital for Special Surgery, New York · completed · Osteoporotic Fractures · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- PTH (1-34) and pelvic fracture healing: A randomized controlled trialU01AR069869 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · fiscal years 2017 to 2021 · $356,297 awarded in 2021Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:28 UTC. The ranking covers the 200 most relevant of 22 PubMed records, and a shared surname and initials can bring in a namesake. All 22 on PubMed
- Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).J Bone Miner Res · 2014208 citationsRCR 8.6
- 111 citationsRCR 4.3
- Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature.Thromb Res · 200588 citationsRCR 2.4
- 52 citationsRCR 2.3
- Comparative assessment of bone mineral measurements using dual X-ray absorptiometry and peripheral quantitative computed tomography.Osteoporos Int · 199845 citationsRCR 1.7
- Retreatment with teriparatide one year after the first teriparatide course in patients on continued long-term alendronate.J Bone Miner Res · 200939 citationsRCR 1.1
- Dexlansoprazole and Esomeprazole Do Not Affect Bone Homeostasis in Healthy Postmenopausal Women.Gastroenterology · 201937 citationsRCR 2.2
- Effect of prior and ongoing raloxifene therapy on response to PTH and maintenance of BMD after PTH therapy.Osteoporos Int · 200833 citationsRCR 1.0
- Increase in Fracture Risk Following Unintentional Weight Loss in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women.J Bone Miner Res · 201632 citationsRCR 1.4
- Daily or Cyclical Teriparatide Treatment in Women With Osteoporosis on no Prior Therapy and Women on Alendronate.J Clin Endocrinol Metab · 201531 citationsRCR 1.3